Daniel C. Howey

[Lys(B28), Pro(B29)]-Human Insulin: A Rapidly Absorbed Analogue of Human Insulin

Daniel C. Howey, Ronald R. Bowsher, Rocco L. Brunelle et al. · Diabetes · 1994 · 451 citations

Pharmacy, Pharmacokinetics, Pharmacology +13

Effects of a Potent and Selective PPAR-α Agonist in Patients With Atherogenic Dyslipidemia or Hypercholesterolemia

Steven E. Nissen, Stephen J. Nicholls, Kathy Wolski et al. · JAMA · 2007 · 130 citations

Pharmacy, Pharmacology, Pharmacotherapy +14

A Randomized, Controlled Study of Once-Daily LY2605541, a Novel Long-Acting Basal Insulin, Versus Insulin Glargine in Basal Insulin–Treated Patients With Type 2 Diabetes

Richard M. Bergenstal, Julio Rosenstock, Richard F. Arakaki et al. · Diabetes Care · 2012 · 115 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Better Glycemic Control and Weight Loss With the Novel Long-Acting Basal Insulin LY2605541 Compared With Insulin Glargine in Type 1 Diabetes

Julio Rosenstock, Richard M. Bergenstal, Thomas Blevins et al. · Diabetes Care · 2012 · 96 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

In vivo evaluation of an electroenzymatic glucose sensor implanted in subcutaneous tissue

Kirk W. Johnson, John J. Mastrototaro, Daniel C. Howey et al. · Biosensors and Bioelectronics · 1992 · 73 citations

Engineering, Bioengineering, Biomedical Engineering +16